$58.6 Million is the total value of Canaan Partners VII LLC's 3 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DRTX | Durata Therapeutics, Inc. | $24,118,000 | -25.5% | 1,902,030 | 0.0% | 41.13% | +12.8% | |
| TRMR | Tremor Video, Inc. | $18,590,000 | -50.4% | 7,944,522 | 0.0% | 31.71% | -24.9% | |
| MRNS | New | Marinus Pharmaceuticals, Inc. | $15,925,000 | – | 2,461,399 | +100.0% | 27.16% | – |
| CMRX | Exit | Chimerix, Inc | $0 | – | -861,664 | -100.0% | -21.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Canaan Partners VIII LLC. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Tremor Video, Inc. | 15 | Q2 2017 | 100.0% |
| LendingClub Corporation | 8 | Q3 2016 | 95.7% |
| Marinus Pharmaceuticals, Inc. | 8 | Q2 2016 | 27.2% |
| Durata Therapeutics, Inc. | 4 | Q3 2014 | 41.1% |
| Tobira Therapeutics, Inc. | 4 | Q1 2016 | 2.1% |
| Chimerix, Inc. | 3 | Q2 2014 | 35.7% |
| Telaria, Inc. | 1 | Q3 2017 | 100.0% |
| Dermira, Inc. | 1 | Q4 2014 | 3.6% |
| Inphi Corporation | 1 | Q4 2014 | 0.7% |
View Canaan Partners VII LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2018-10-25 |
| 4 | 2018-10-24 |
| 4 | 2018-08-30 |
| 4 | 2018-08-28 |
| 4 | 2018-08-23 |
| 4 | 2018-08-20 |
| 4 | 2018-08-15 |
| 4 | 2018-05-31 |
| 4 | 2018-05-24 |
| 4 | 2018-05-21 |
View Canaan Partners VII LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.